Ambra | Council for Inclusive Capitalism

Ambra was created to develop research in the field of solvent-free extraction of natural phytocomplexes. We develop 100% natural formulations with the highest quality standards, for the food, cosmetic and pharmaceutical sectors. we provide analytical tools to evaluate the efficacy and quality of food and phytotherapeutic products. We develop natural medicines.

Purpose

Ambra is, by statute, a benefit company.

We believe that the companies of the future must have a socially positive and ecologically sustainable impact, aiming at a regenerative and non-destructive vision of industry. The analysis laboratory was born together with the solvent-free processing project, in the context of research for life sciences. We believe that the preservation of the phytocomplex and the vitality of the plant have a very important impact on phytotherapeutic products. In fact, together with new solventless processing methods, we have developed new methods to analyze these characteristics, as well as the concentrations of the different molecules.

Edoardo Alfinito

CEO, Ambra

Find out more

We believe it is vital to state clearly to the world the set of our beliefs about Inclusive Capitalism. As such, we start with our Statement of Guiding Principles for Inclusive Capitalism. Knowing that words alone are not enough, each of us is making a series of commitments about how we will operate our institutions so that they help achieve Inclusive Capitalism. These commitments are forward-looking statements based on current goals, expectations and assumptions, which are not guarantees of future performance. For more information, please refer to our Terms of Use

Filter by commitments

View all

People

Planet

Principles of Governance

Prosperity

Summary

Ambra will bring to market at least 10 different types of all-natural medicines and medical devices and products from sustainable and regenerative supply chains by 2026.

Activities & Initiatives

Ambra will perform green pharmaceutical R&D to develop pharmaceutical grade medications that respect and enhance life on earth. We will develop a certified quality system and training to physicians and pharmacists to demonstrate that medicinal plants have less risk for health and are derived from a sustainable supply chain. Through this we will bring to market at least 10 different types of all-natural medicines and medical devices and products from sustainable and regenerative supply chains.

Measures & Targets

Ambra will bring to market at least 10 different types of all-natural medicines and medical devices and products from sustainable and regenerative supply chains by 2026.

Sign up your company

Recognizing it will take alignment of all our organizations to scale impact globally, we invite you to join the movement as a Steward of Inclusive Capitalism. Together, the collective action of Council members will contribute to a fairer, more inclusive and sustainable future for all people and our planet.